Under 21 CFR Part 312, what is the primary purpose of an Investigational New Drug (IND) application?
-
A
To obtain final marketing approval from FDA
-
B
To authorize shipment of an unapproved drug for clinical investigation
-
C
To request orphan drug designation for a rare disease product
-
D
To notify FDA of a post-market safety issue